There is no product in the shopping cart, buy it!
The glycosylation pattern of an antibody is a key quality attribute, which has an important impact on the structure, safety, stability, and immunogenicity of the antibody. Comprehensive glycosylation analysis of antibodies helps evaluate the impact of different glycosyl structures on antibody functions and activity. Creative Biolabs has developed a multifunctional Glycoprotein Analysis Platform. We use various mass spectrometry techniques to comprehensively identify the glycoforms of antibodies and conduct professional glycosylation profile assessments of Fab and Fc domains.
Glycoprofiling analysis of antibodies is generally performed according to the following steps.
We collect and extract antibody samples, and perform protein purification and enrichment processing on the samples to reduce the impact of interfering substances on glycosylation analysis and eliminate non-specific signals.
We add an appropriate enzyme (such as PNGase F) to the antibody sample and incubate it for several hours at 37 °C to remove glycosylation. The released glycans are then labeled.
We use liquid chromatography technology or capillary electrophoresis to elute and separate labeled glycans and calculate the relative glycan composition.
To correctly identify the labeled glycans, we couple the separation system to an MS system and use positive ion mode to collect precursor ions and fragment product ions of the sample. Moreover, we analyze the glycan composition in the antibody sample and generate detailed reports according to the detected mass spectrometry data, including glycan type, relative abundance, possible modification types, etc., thereby providing clients with comprehensive analysis results on the antibody glycans.
Fig.1 The workflow of antibody glycoprofiling.
Technology: Capillary electrophoresis-mass spectrometry (CE-ESI-MS)
Journal: Talanta
IF: 6.556
Published: 2018
Results: The authors used CE-ESI-MS technology to comprehensively characterize the N-glycosylation of monoclonal antibodies (mAbs) and relative quantification of the glycosylation profiles of mAbs produced in different cell lines was performed. The results showed that the CE-ESI-MS method had good reproducibility and stability and could be used as an alternative to liquid chromatography-mass spectrometry (LC-ESI-MS) for glycosylation analysis.
Fig.2 CE-ESI-MS technology for antibody glycoprofiling.1
Creative Biolabs has experienced scientific research teams dedicated to providing global clients with a wide range of antibody glycoprofiling analyses. Whether you use glycoprofiling for research, development, or quality control, you can trust us to provide quality glycoprofiling services tailored to your specific needs. Please feel free to contact us if you are interested in our glycoprofiling analysis.
Reference